Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Children's Oncology Group
With
National Cancer Institute (NCI)
OBJECTIVES:
I. Establish a mechanism to bank specimens of tumor cells and host germline DNA from patients with acute lymphoblastic leukemia (ALL) at first and subsequent relapse.
II. Make these specimens available to qualified researchers to study the biology of ALL.
OUTLINE: This is a multicenter study.
Patients undergo collection of bone marrow and peripheral blood at diagnosis of relapse and/or at the end of the first month of treatment.
Patients are followed periodically for up to 10 years.
Age
0–30
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of acute lymphoblastic leukemia (ALL) or prior history of non-Hodgkin lymphoma
In first or subsequent marrow relapse with ≥ 25% blasts in bone marrow and/or peripheral blood
Bone marrow and/or peripheral blood samples (≥ 5 mL) required at the time of diagnosis of relapse
No concurrent systemic antileukemic treatment administered for current relapse
* Intrathecal chemotherapy allowed
* On-therapy relapse allowed
Clareo Health | Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
